Literature DB >> 27284207

Phenolic Derivatives from the Root Bark of Oplopanax horridus.

Wei-Hua Huang1, Qing-Wen Zhang2, Chong-Zhi Wang3, Chun-Su Yuan3, Shao-Ping Li2.   

Abstract

Four new phenolic derivatives, including two phenylpropanoid glycosides, one benzoate glycoside, and one lignan glycoside, together with one known glyceride, were isolated from the root bark of Oplopanax horridus. The structures of the new compounds were elucidated as 3-{4-[(6-O-acetyl-β-D-glucopyranosyl) oxy]-3,5-dimethoxyphenylpropanoic acid (1), (+)-[5,6,7,8-tetrahydro-7- (hydroxylmethyl)-10,11-dimehoxydibenzo[a,c][8]annulen-6-yl]methyl β-D-glucopyranoside (2), (+)-methyl 4-[6-O-{3-hydroxy-3-methyl-5-(1-methylpropyl)oxy]-5-oxopentanoyl}-4-O-(β-D-glucopyranosyl)-β-D-glucopyranosyl)oxy]-3-methoxybenzoate (3), and 2-methoxy-4-[(1E)-3-methoxy-3-oxoprop-1-en-1-yl]phenyl 6-O-{3-hydroxy-3-methyl-5-[(1-methylpropyl)oxy]-5-oxopentanoyl-4-O-β-D-glucopyranosyl-β-D-glucopyranoside (4) on the basis of spectroscopic techniques including NMR and MS analyses. The known compound was identified as glycer-2-yl ferulate (5) by comparing its physical and spectral data with those reported in the literature.

Entities:  

Keywords:  Oplopanax; Oplopanax horridus; lignan; phenylpropanoid

Year:  2015        PMID: 27284207      PMCID: PMC4896482          DOI: 10.1002/hlca.201300439

Source DB:  PubMed          Journal:  Helv Chim Acta        ISSN: 0018-019X            Impact factor:   2.164


  10 in total

1.  Profiling of phenylpropanoids in transgenic low-sinapine oilseed rape (Brassica napus).

Authors:  Karina Wolfram; Jürgen Schmidt; Victor Wray; Carsten Milkowski; Willibald Schliemann; Dieter Strack
Journal:  Phytochemistry       Date:  2010-05-05       Impact factor: 4.072

2.  Studies on the anti-psoriasis constituents of Oplopanax elatus Nakai.

Authors:  De-Qiang Dou; Xiao-Yan Hu; Yue-Ran Zhao; Ting-Guo Kang; Feng-Yun Liu; Hai-Xue Kuang; David C Smith
Journal:  Nat Prod Res       Date:  2009       Impact factor: 2.861

Review 3.  Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention.

Authors:  Wu-Yang Huang; Yi-Zhong Cai; Yanbo Zhang
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

Review 4.  Chemical constituents of the plants from the genus Oplopanax.

Authors:  Wei-Hua Huang; Qing-Wen Zhang; Chun-Su Yuan; Chong-Zhi Wang; Shao-Ping Li; Hong-Hao Zhou
Journal:  Chem Biodivers       Date:  2014-02       Impact factor: 2.408

Review 5.  Anticancer lignans--from discovery to biotechnology.

Authors:  I Ionkova
Journal:  Mini Rev Med Chem       Date:  2011-09       Impact factor: 3.862

Review 6.  Plant phenylpropanoids as emerging anti-inflammatory agents.

Authors:  L Korkina; V Kostyuk; C De Luca; S Pastore
Journal:  Mini Rev Med Chem       Date:  2011-09       Impact factor: 3.862

Review 7.  Chemical and pharmacological studies of Oplopanax horridus, a North American botanical.

Authors:  Tyler Calway; Guang-Jian Du; Chong-Zhi Wang; Wei-Hua Huang; Jing Zhao; Shao-Ping Li; Chun-Su Yuan
Journal:  J Nat Med       Date:  2011-11-20       Impact factor: 2.343

8.  Oplopanphesides A-C, three new phenolic glycosides from the root barks of Oplopanax horridus.

Authors:  Wei-Hua Huang; Qing-Wen Zhang; Lan-Zhen Meng; Chun-Su Yuan; Chong-Zhi Wang; Shao-Ping Li
Journal:  Chem Pharm Bull (Tokyo)       Date:  2011       Impact factor: 1.645

Review 9.  Antiviral activity of phytochemicals: a comprehensive review.

Authors:  Rajesh Naithani; Loredana C Huma; Louis E Holland; Deepak Shukla; David L McCormick; Rajendra G Mehta; Robert M Moriarty
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

10.  Isolation and identification of two new polyynes from a North American ethnic medicinal plant--Oplopanax horridus (Smith) Miq.

Authors:  Wei-Hua Huang; Qing-Wen Zhang; Chong-Zhi Wang; Chun-Su Yuan; Shao-Ping Li
Journal:  Molecules       Date:  2010-02-23       Impact factor: 4.411

  10 in total
  1 in total

Review 1.  Oplopanax horridus: Phytochemistry and Pharmacological Diversity and Structure-Activity Relationship on Anticancer Effects.

Authors:  Kai Wu; Chong-Zhi Wang; Chun-Su Yuan; Wei-Hua Huang
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-13       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.